1. Home
  2. ALMS vs SDHY Comparison

ALMS vs SDHY Comparison

Compare ALMS & SDHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALMS
  • SDHY
  • Stock Information
  • Founded
  • ALMS 2021
  • SDHY 2020
  • Country
  • ALMS United States
  • SDHY United States
  • Employees
  • ALMS N/A
  • SDHY N/A
  • Industry
  • ALMS
  • SDHY Finance/Investors Services
  • Sector
  • ALMS
  • SDHY Finance
  • Exchange
  • ALMS NYSE
  • SDHY Nasdaq
  • Market Cap
  • ALMS 469.0M
  • SDHY 405.6M
  • IPO Year
  • ALMS 2024
  • SDHY N/A
  • Fundamental
  • Price
  • ALMS $8.82
  • SDHY $16.24
  • Analyst Decision
  • ALMS Strong Buy
  • SDHY
  • Analyst Count
  • ALMS 6
  • SDHY 0
  • Target Price
  • ALMS $29.60
  • SDHY N/A
  • AVG Volume (30 Days)
  • ALMS 148.8K
  • SDHY 94.0K
  • Earning Date
  • ALMS 02-15-2025
  • SDHY 01-01-0001
  • Dividend Yield
  • ALMS N/A
  • SDHY 8.46%
  • EPS Growth
  • ALMS N/A
  • SDHY N/A
  • EPS
  • ALMS N/A
  • SDHY 1.07
  • Revenue
  • ALMS N/A
  • SDHY N/A
  • Revenue This Year
  • ALMS N/A
  • SDHY N/A
  • Revenue Next Year
  • ALMS N/A
  • SDHY N/A
  • P/E Ratio
  • ALMS N/A
  • SDHY $14.31
  • Revenue Growth
  • ALMS N/A
  • SDHY N/A
  • 52 Week Low
  • ALMS $7.66
  • SDHY $13.93
  • 52 Week High
  • ALMS $13.53
  • SDHY $15.50
  • Technical
  • Relative Strength Index (RSI)
  • ALMS N/A
  • SDHY 36.32
  • Support Level
  • ALMS N/A
  • SDHY $16.11
  • Resistance Level
  • ALMS N/A
  • SDHY $16.60
  • Average True Range (ATR)
  • ALMS 0.00
  • SDHY 0.12
  • MACD
  • ALMS 0.00
  • SDHY -0.05
  • Stochastic Oscillator
  • ALMS 0.00
  • SDHY 22.30

About ALMS ALUMIS INC

Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.

About SDHY PGIM Short Duration High Yield Opportunities Fund

PGIM Short Duration High Yield Opportunities is a closed-end management investment company. The fund's investment objective is to provide total return, through a combination of current income and capital appreciation. Its seeks to achieve its objective by investing in a diversified portfolio of high yield fixed income instruments.

Share on Social Networks: